This article is more than 5 years old. Information may no longer be current.
ACIP releases 2014 recommended adult immunization schedule
Click Here to Manage Email Alerts
The CDC’s Advisory Committee on Immunization Practices released the recommended adult immunization schedule. The updated schedule was published in an early release of MMWR and the Annals of Internal Medicine.
This schedule was also approved by the American Academy of Family Physicians, American College of Physicians, American College of Obstetricians and Gynecologists, and American College of Nurse-Midwives.
One key update to the schedule is the recommendation for the Haemophilus influenzae type b (Hib) vaccine. The vaccine is recommended for adults at increased risk for Hib if they have not received the vaccine before. The exception is people with HIV because they have a low risk of Hib infection. In addition, adults who have had a hematopoietic stem cell transplant are recommended to receive a three-dose series of Hib vaccine, 6 to 12 months after transplant, regardless of prior vaccination.
Another key change is that the zoster vaccine is no longer indicated for health care workers.
The following footnote changes were also made:
- Information on influenza vaccines for people with egg allergy: recombinant influenza and inactivated influenza vaccines can be used among people with hives-only allergy to eggs;
- Language regarding the tetanus-diphtheria (Td) and tetanus-diphtheria-acelluar pertussis (Tdap) vaccines was updated to be in line with the pediatric schedule: a single dose of Tdap is recommended for unvaccinated people aged 11 and older, with a Td booster given every 10 years;
- Footnotes for the HPV vaccine include new information to clarify timing between second and third doses, and were updated to be in line with the pediatric schedule;
- Footnotes for the 13-valent pneumococcal conjugate (PCV13; Prevnar 13, Pfizer) vaccine were moved to precede footnotes for the 23-valent pneumococcal polysaccharide vaccine (PPSV23), to remind providers that PCV13 is recommended to be given before PPSV23 for those who are to receive both vaccines;
- Meningococcal vaccine footnotes were updated to clarify the number of doses and who should receive the meningococcal conjugate vaccine vs. the meningococcal polysaccharide vaccine.
For more information:
Bridges C. Ann Intern Med. 2014;160:190-198.